Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleksander Edelman

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
EMBO Molecular Medicine|August 29, 2013
Discovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domainNorbert Odolczyk, Janine Fritsch, Caroline Norez, et al.
Scientific Reports|April 26, 2019
Airway surface liquid acidification initiates host defense abnormalities in Cystic FibrosisJuliette Simonin, Emmanuelle Bille, Gilles Crambert, et al.
Scientific Reports|November 23, 2019
Author Correction: Airway surface liquid acidification initiates host defense abnormalities in Cystic FibrosisJuliette Simonin, Emmanuelle Bille, Gilles Crambert, et al.
Nature Medicine|October 10, 2018
Structure-guided combination therapy to potently improve the function of mutant CFTRsGuido Veit, Haijin Xu, Elise Dreano, et al.
Journal of Molecular Biology|June 1, 2016
Rattlesnake Phospholipase A2 Increases CFTR-Chloride Channel Current and Corrects ∆F508CFTR Dysfunction: Impact in Cystic FibrosisGrazyna Faure, Naziha Bakouh, Stéphane Lourdel, et al.
American Journal of Respiratory and Critical Care Medicine|October 29, 2015
rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis MiceDragana Vidović, Marianne S Carlon, Mélanie F da Cunha, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 8, 2023
Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis childrenAnnalisa Orenti, Iwona Pranke, Caroline Faucon, et al.
The European Respiratory Journal|September 11, 2023
Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescriptionElise Dreano, Pierre Régis Burgel, Aurelie Hatton, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
EMBO Molecular Medicine|August 29, 2013
Discovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domainNorbert Odolczyk, Janine Fritsch, Caroline Norez, et al.
Scientific Reports|April 26, 2019
Airway surface liquid acidification initiates host defense abnormalities in Cystic FibrosisJuliette Simonin, Emmanuelle Bille, Gilles Crambert, et al.
Scientific Reports|November 23, 2019
Author Correction: Airway surface liquid acidification initiates host defense abnormalities in Cystic FibrosisJuliette Simonin, Emmanuelle Bille, Gilles Crambert, et al.
Nature Medicine|October 10, 2018
Structure-guided combination therapy to potently improve the function of mutant CFTRsGuido Veit, Haijin Xu, Elise Dreano, et al.
Journal of Molecular Biology|June 1, 2016
Rattlesnake Phospholipase A2 Increases CFTR-Chloride Channel Current and Corrects ∆F508CFTR Dysfunction: Impact in Cystic FibrosisGrazyna Faure, Naziha Bakouh, Stéphane Lourdel, et al.
American Journal of Respiratory and Critical Care Medicine|October 29, 2015
rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis MiceDragana Vidović, Marianne S Carlon, Mélanie F da Cunha, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 8, 2023
Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis childrenAnnalisa Orenti, Iwona Pranke, Caroline Faucon, et al.
The European Respiratory Journal|September 11, 2023
Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescriptionElise Dreano, Pierre Régis Burgel, Aurelie Hatton, et al.
Pageof 11